Latest period
$5.69M
YoY change
-74.0%
5Y CAGR
—
Peak year (2022)
$82.11M
Latest annual
$4.41M
Total Debt history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: $4.41M
Total Debt growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: -74.0%
Total Debt history table for Alto Neuroscience (ANRO) from 2021 to 2025
| 2025 | $4.41M | -74.0% | −$12.54M | ||
| 2024 | $16.94M | +69.7% | +$6.96M | ||
| 2023 | $9.99M | -87.8% | −$72.12M | ||
| 2022 | $82.11M | +115.1% | +$43.94M | ||
| 2021 | $38.16M | — | — |
- 2025$4.41M-74.0%
- 2024$16.94M+69.7%
- 2023$9.99M-87.8%
- 2022$82.11M+115.1%
- 2021$38.16M—
Total Debt values are taken from Alto Neuroscience's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's latest reported total debt is $5.69M. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Alto Neuroscience (ANRO) total debt is $4.41M – plunged 74.0% year-over-year.
Across the available history, total debt reached its high of $82.11M in 2022 and its low of $4.41M in 2025.
Alto Neuroscience Total Debt by Year
Alto Neuroscience Total Debt 2025: $4.41M
Alto Neuroscience total debt in 2025 was $4.41M, plunged 74.0% below 2024. This figure represents the lowest annual value in the available history.
Alto Neuroscience Total Debt 2024: $16.94M
2024's total debt for Alto Neuroscience came in at $16.94M, surged 69.7% from 2023.
Alto Neuroscience Total Debt 2023: $9.99M
Alto Neuroscience posted total debt of $9.99M in 2023, plunged 87.8% below 2022.
Alto Neuroscience Total Debt 2022: $82.11M
In 2022, Alto Neuroscience reported total debt of $82.11M, surged 115.1% from 2021. This figure represents the highest annual value in the available history.
Alto Neuroscience Total Debt 2021: $38.16M
Alto Neuroscience total debt in 2021 was $38.16M.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Total Debt
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation